These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15577260)
61. Kinetic mechanisms in the reduction of aldehydes and ketones catalyzed by rabbit liver aldehyde reductases and hydroxysteroid dehydrogenases. Sawada H; Hara A; Nakayama T; Hayashibara M J Biochem; 1982 Jul; 92(1):185-91. PubMed ID: 6749832 [TBL] [Abstract][Full Text] [Related]
62. Mouse liver 3-hydroxyhexobarbital dehydrogenase: purification and substrate specificity. Takenoshita R; Naitoh K; Toki S Prog Clin Biol Res; 1989; 290():279-91. PubMed ID: 2657756 [No Abstract] [Full Text] [Related]
63. Identification of two dihydrodiol dehydrogenases associated with 3(17)alpha-hydroxysteroid dehydrogenase activity in mouse kidney. Nakagawa M; Tsukada F; Nakayama T; Matsuura K; Hara A; Sawada H J Biochem; 1989 Oct; 106(4):633-8. PubMed ID: 2691507 [TBL] [Abstract][Full Text] [Related]
64. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Eberhart DC; Gemzik B; Halvorson MR; Parkinson A Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247 [TBL] [Abstract][Full Text] [Related]
65. Characterisation of a novel mouse liver aldo-keto reductase AKR7A5. Hinshelwood A; McGarvie G; Ellis E FEBS Lett; 2002 Jul; 523(1-3):213-8. PubMed ID: 12123834 [TBL] [Abstract][Full Text] [Related]
66. Demonstration of 3 alpha(17 beta)-hydroxysteroid dehydrogenase distinct from 3 alpha-hydroxysteroid dehydrogenase in hamster liver. Ohmura M; Hara A; Nakagawa M; Sawada H Biochem J; 1990 Mar; 266(2):583-9. PubMed ID: 2317205 [TBL] [Abstract][Full Text] [Related]
67. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily. Steckelbroeck S; Oyesanmi B; Jin Y; Lee SH; Kloosterboer HJ; Penning TM J Pharmacol Exp Ther; 2006 Mar; 316(3):1300-9. PubMed ID: 16339391 [TBL] [Abstract][Full Text] [Related]
68. Complementary deoxyribonucleic acid cloning and enzymatic characterization of a novel 17beta/3alpha-hydroxysteroid/retinoid short chain dehydrogenase/reductase. Su J; Lin M; Napoli JL Endocrinology; 1999 Nov; 140(11):5275-84. PubMed ID: 10537158 [TBL] [Abstract][Full Text] [Related]
69. Kinetic and stereochemical characterization of hamster liver 3 alpha-hydroxysteroid dehydrogenase and 3 alpha(17 beta)-hydroxysteroid dehydrogenase. Sawada H; Hara A; Ohmura M; Nakayama T; Deyashiki Y J Biochem; 1991 May; 109(5):770-5. PubMed ID: 1917902 [TBL] [Abstract][Full Text] [Related]
70. Characterization of a novel murine aldo-keto reductase. Bohren KM; Barski OA; Gabbay KH Adv Exp Med Biol; 1997; 414():455-64. PubMed ID: 9059651 [No Abstract] [Full Text] [Related]
71. Comparison of glutathione S-transferases in mouse, guinea pig, rabbit and hamster liver cytosol to those in rat liver. Igarashi T; Tomihari N; Ohmori S; Ueno K; Kitagawa H; Satoh T Biochem Int; 1986 Oct; 13(4):641-8. PubMed ID: 3801038 [TBL] [Abstract][Full Text] [Related]
72. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. O'connor T; Ireland LS; Harrison DJ; Hayes JD Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318 [TBL] [Abstract][Full Text] [Related]
73. Metabolism of pravastatin sodium by 3 alpha-hydroxysteroid dehydrogenase. Muramatsu S; Komokata Y; Tanaka Y; Takahagi H Biol Pharm Bull; 1997 Nov; 20(11):1199-203. PubMed ID: 9401732 [TBL] [Abstract][Full Text] [Related]
78. Species variation and stereoselectivity in the metabolism of nicotine enantiomers. Nwosu CG; Crooks PA Xenobiotica; 1988 Dec; 18(12):1361-72. PubMed ID: 3245230 [TBL] [Abstract][Full Text] [Related]
79. Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol. Itoh K; Hoshino K; Endo A; Asakawa T; Yamakami K; Noji C; Kosaka T; Tanaka Y Chirality; 2006 Sep; 18(9):698-706. PubMed ID: 16823812 [TBL] [Abstract][Full Text] [Related]
80. Disposition of allylic oxidation pathway metabolites of racemic hexobarbital in the rat. Van der Graaff M; Vermeulen NP; Vinks MH; Breimer DD Eur J Drug Metab Pharmacokinet; 1986; 11(2):107-11. PubMed ID: 3770011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]